353 related articles for article (PubMed ID: 20581724)
1. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
2. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
[TBL] [Abstract][Full Text] [Related]
4. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
Asnis GM; Chakraburtty A; DuBoff EA; Krystal A; Londborg PD; Rosenberg R; Roth-Schechter B; Scharf MB; Walsh JK
J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
Taleghani SY; Etesam F; Esfandbod M
Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
[TBL] [Abstract][Full Text] [Related]
6. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
[TBL] [Abstract][Full Text] [Related]
7. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition.
Joffe H; Petrillo LF; Koukopoulos A; Viguera AC; Hirschberg A; Nonacs R; Somley B; Pasciullo E; White DP; Hall JE; Cohen LS
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1044-54. PubMed ID: 21525161
[TBL] [Abstract][Full Text] [Related]
8. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
[TBL] [Abstract][Full Text] [Related]
9. Management of hot flashes in breast cancer survivors and men with prostate cancer.
Stearns V
Curr Oncol Rep; 2004 Jul; 6(4):285-90. PubMed ID: 15161582
[TBL] [Abstract][Full Text] [Related]
10. Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.
Ensrud KE; Guthrie KA; Hohensee C; Caan B; Carpenter JS; Freeman EW; LaCroix AZ; Landis CA; Manson J; Newton KM; Otte J; Reed SD; Shifren JL; Sternfeld B; Woods NF; Joffe H
Sleep; 2015 Jan; 38(1):97-108. PubMed ID: 25325454
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.
Vitolins MZ; Griffin L; Tomlinson WV; Vuky J; Adams PT; Moose D; Frizzell B; Lesser GJ; Naughton M; Radford JE; Shaw EG
J Clin Oncol; 2013 Nov; 31(32):4092-8. PubMed ID: 24081940
[TBL] [Abstract][Full Text] [Related]
13. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
[TBL] [Abstract][Full Text] [Related]
14. Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.
Capriglione S; Plotti F; Montera R; Luvero D; Lopez S; Scaletta G; Aloisi A; Serra GB; Angioli R
Gynecol Oncol; 2016 Dec; 143(3):584-588. PubMed ID: 27751589
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
16. Ameliorating hot flashes/awakenings in the context of breast cancer treatments.
Shaver JL
Menopause; 2010; 17(5):889-91. PubMed ID: 20717060
[No Abstract] [Full Text] [Related]
17. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
18. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
Stearns V; Slack R; Greep N; Henry-Tilman R; Osborne M; Bunnell C; Ullmer L; Gallagher A; Cullen J; Gehan E; Hayes DF; Isaacs C
J Clin Oncol; 2005 Oct; 23(28):6919-30. PubMed ID: 16192581
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
Buijs C; Mom CH; Willemse PH; Marike Boezen H; Maurer JM; Wymenga AN; de Jong RS; Nieboer P; de Vries EG; Mourits MJ
Breast Cancer Res Treat; 2009 Jun; 115(3):573-80. PubMed ID: 18670875
[TBL] [Abstract][Full Text] [Related]
20. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
Stearns V; Isaacs C; Rowland J; Crawford J; Ellis MJ; Kramer R; Lawrence W; Hanfelt JJ; Hayes DF
Ann Oncol; 2000 Jan; 11(1):17-22. PubMed ID: 10690382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
